Clinical trials
Pulmonary clinical trials
Below are recruiting pulmonary clinical trials, each written for real people, not researchers. We’re tracking 1,310 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06275230Recruiting
Growing lung stem cells from COPD patients
This trial aims to grow lung stem cells and create mini-lungs (organoids) from the tissue of people with COPD. It may help researchers understand the disease better and develop new treatments.
Beijing, Beijing MunicipalityAges 18–55 - NCT07424326Recruiting
Extended ablation vs. standard treatment for persistent atrial fibrillation
This trial compares two catheter ablation techniques for people with persistent atrial fibrillation (a type of irregular heartbeat that doesn't go away on its own). It will test whether a more extensive ablation (burning more heart tissue) works better than the standard procedure of isolating the pulmonary veins (the veins that bring blood from the lungs to the heart). If you have this condition and have had at least one episode in the past year, this study might help you find a more effective treatment.
OlomoucAges 18–80 - NCT06069115Recruiting
How radiation affects lung function in breast cancer patients
This study looks at how radiation therapy for breast cancer may affect your lungs over time. Researchers will measure lung function and see if problems develop, so they can better understand and protect patients.
Novosibirsk, Novosibirsk OblastAges 18 years+ - NCT07407543RecruitingPhase 1
Study of SRN001 in healthy Korean and Caucasian men
This trial tests a new drug called SRN001 in healthy men to see how safe it is and how the body processes it. It may help find the right dose for future studies.
SeoulAges 19–60 - NCT07414108Recruiting
Predicting response to breathing support in COPD
This study looks at whether nighttime breathing problems can predict long-term success with a non-invasive breathing machine in people with COPD who have high carbon dioxide levels in their blood. The goal is to help doctors decide who will benefit most from this therapy.
BolognaAges 18 years+ - NCT07410975RecruitingPhase 2
Immunotherapy and chemo before surgery for lung cancer
This trial tests combining two immunotherapy drugs (anti-CTLA-4 antibody and sintilimab) with chemotherapy before surgery for stage II-III non-small cell lung cancer. The goal is to see if this approach helps shrink tumors and improve outcomes.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07408635RecruitingPhase 2
New Immunotherapy Plus Chemotherapy Before Lung Cancer Surgery
This trial tests a new combination of an immunotherapy drug (IBI363) plus chemotherapy before surgery in people with Stage III lung cancer that can't be removed at first. The goal is to shrink the tumor so it can be surgically removed.
ShanghaiAges 18 years+ - NCT06821451Recruiting
Robot-guided dye marking for lung nodule surgery
This trial tests a new way to find and remove small lung nodules using a robot-guided camera to mark the nodule with dye, then a video-assisted surgery to remove it. It may help patients whose nodules are hard to locate during surgery.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT06587906Recruiting
Complications after skull base tumor surgery
This study looks at how often problems happen after surgery to remove skull base tumors. It may help doctors better understand and reduce risks for future patients.
BeijingAges 18 years+ - NCT07404826Recruiting
PEP Buddy device test in COPD lung rehab
This trial tests if a small device (PEP Buddy) helps people with COPD breathe easier during pulmonary rehabilitation exercises.
Cincinnati, OhioAges 40–89 - NCT07406048Recruiting
Effectiveness of a triple inhaler for COPD in Brazil
This study looks at how well a triple inhaler (BDP/FF/GB) works for people with severe COPD in Brazil. It may help those who have had at least one flare-up in the past year.
São Paulo, São PauloAges 40 years+ - NCT07402551RecruitingPhase 2
Testing RC1416 injection for COPD flare-ups
This trial tests an injection called RC1416 for people with moderate-to-severe COPD who still have flare-ups despite using triple inhaler therapy. It may help reduce those flare-ups and improve breathing.
Hefei, AnhuiAges 40–85 - NCT05908955Recruiting
Atrial fibrillation ablation with extra vein targeting
This trial studies a modified ablation procedure that targets the superior vena cava in addition to the pulmonary veins to help stop episodes of paroxysmal (coming and going) atrial fibrillation. It may help people whose symptoms continue despite antiarrhythmic medicines.
Beijing, Beijing MunicipalityAges 40–75 - NCT04731558RecruitingPhase 4
Blood clot prevention before versus after liver surgery
This study compares two approaches to preventing blood clots around the time of liver surgery. If you’re having planned liver surgery, it may help doctors choose the safest timing and method for clot prevention.
HelsinkiAges 18 years+ - NCT07406659Recruiting
Inspiratory muscle training for COPD patients
This trial compares different types of breathing muscle exercises for people with COPD. It aims to find which training is most helpful for improving breathing and daily life.
Yalova, YalovaAges 18 years+ - NCT07399119Enrolling by invitation
Study on Wim Hof Method and Exercise in Healthy Young Adults
This trial tests how the Wim Hof method (a breathing and cold exposure technique) affects your heart and exercise performance during aerobic training. It is designed for healthy young adults.
Beirut, Tariq EL JedidaAges 18–25 - NCT07401615Recruiting
Repeat SBRT for Recurrent Lung Tumors
This trial tests giving another round of intense radiation (SBRT) to lung tumors that have come back after a previous SBRT treatment. It is for people who cannot have surgery and whose other cancer (if any) is under control.
Bergamo, BergamoAges 18 years+ - NCT06168162Recruiting
Personalized breathing support during weight-loss surgery
This trial tests whether a personalized breathing setting during surgery can lower the risk of lung complications after weight-loss surgery. If you have a high risk of lung issues, you may be eligible.
Cairo, Cairo GovernorateAges 16 years+ - NCT06798077Recruiting
Chronic Lung Disease and Multiple Health Issues Study
This study follows people with chronic airway diseases like COPD, asthma, or bronchiectasis who were recently hospitalized for a worsening of their condition. It aims to understand how these diseases affect overall health and other medical problems over time.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07395297Recruiting
Airway clearance therapy for ICU lung infections
This trial tests a new airway clearance device in ICU patients with pneumonia. It may help clear mucus from your lungs and improve breathing without needing a breathing tube.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07389434Recruiting
Testing reused catheters for atrial fibrillation treatment
This trial tests whether reusing special catheters to treat atrial fibrillation is safe, effective, and better for costs and the environment. It may help people with atrial fibrillation who need a procedure called pulmonary vein isolation.
ZagrebAges 18 years+ - NCT06833554Recruiting
Breast milk cells and infant health in mothers with metabolic conditions
This trial studies how special cells in breast milk from mothers with metabolic diseases (like obesity or diabetes) affect infant development and lung infection response after a nutritional intervention. It aims to understand if improving mother's diet can strengthen baby's immune system.
Málaga, MalagaAges 18–50 - NCT05703191Recruiting
Tests an inhaled nitric oxide system for newborn lung pressure
This study looks at whether an inhaled nitric oxide generator and delivery system can help newborns with high lung blood pressure (pulmonary hypertension). It may help improve oxygen levels during breathing support, but it requires specific medical eligibility and informed consent.
Guangzhou, GuangzhouAges Any age - NCT07387601Recruiting
Peer education for TB treatment in Ethiopia
This trial tests whether having a peer educator (someone who has been through TB treatment) help you stay on track with your medicines and get better. It is for adults with new, easy-to-treat TB in South Omo and Ari Zone, Ethiopia.
Jinka, Southern EthiopiaAges 18 years+
Hear when a new Pulmonary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pulmonary?
- Yes. Clin2 currently lists 1,310 recruiting pulmonary studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pulmonary trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pulmonary trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.